期刊文献+

类风湿关节炎共同表位QK/RRAA对蛋白激酶A通路的抑制作用 被引量:4

Inhibitory effect of rheumatoid arthritis shared epitope QK/RRAA on protein kinase A (PKA) signaling
原文传递
导出
摘要 目的 研究类风湿关节炎 (RA)共同表位QK/RRAA及其变异对细胞内蛋白激酶A(PKA)信号通路的影响。方法 测定HLA DRβ1 0 40 4及其变异体转基因细胞内PKA、cAMP及腺苷环化酶 (AC)的浓度及活性。结果 HLA DRβ1 0 40 4转基因细胞的PKA活力、cAMP水平及AC活力明显低于HLA DRβ1 0 40 3转基因细胞株 (P <0 0 1)。HLA DRβ1 0 40 4序列第 70~ 74位氨基酸QRRAA中的Q70 及A74 是抑制PKA信号通路的关键氨基酸。结论 类风湿关节炎共同表位QK/RRAA的表达可抑制PKA、cAMP和AC的活性 。 Objective To study the effect of rheumatoid arthritis (RA) shared epitope on protein kinase A (PKA) signaling.Methods The activities of adenylate cyclase (AC),cAMP and PKA in transfectants expressing RA shared epitope and their mutants were determined.Results HLA DRβ10404 transfectant produced a significant lower levels of AC,cAMP and PKA compared with HLA DRβ10403 transfectants ( P <0 01).Positions 70 and 74 of DRβ10404 sequence QRRAA were critical in PKA signaling.Conclusion RA shared epitope suppresses PKA signaling.Q70 and A74 are the key residues in PKA signal transduction and may mediate abnormal intracellular signaling in RA.
出处 《中华风湿病学杂志》 CAS CSCD 2001年第3期145-147,共3页 Chinese Journal of Rheumatology
基金 国家自然科学基金!资助项目 (3 9970 697) 中华医学专项人才基金!部分资助项目 (68792 745 )
关键词 类风湿关节炎 HLA-DR1抗原 cAMP依赖性蛋白激酶 免疫显性表位 Arthritis,rheumatoid HLA DR1 antigen Cyclic AMP dependent protein kinases Immunodominant epitopes
  • 相关文献

参考文献4

二级参考文献4

共引文献1

同被引文献68

  • 1Firestein GS. Evolving concepts of rheumatoid arthritis[J]. Nature,2003,423(6937):356-361.
  • 2Seldin MF, Amos CI, Ward R, et al. The genetics revolu- tion and the assault on rheumatoid arthritis [J]. Arthritis Rheum, 1999,42(6): 1071-1079.
  • 3Kinikli G, Ate~ A, Turgay M, et al. HLA-DRB1 genes and disease severity in rheumatoid arthritis in Turkey[J]. Scand J Rheumatol,2003,32(5):277-280.
  • 4Varga E, Palkonyai E, Temesvdri P, et al. The role of HLA-DRBI*04 alleles and their association with HLA- DQB genes in genetic susceptibility to rheumatoid arthri- tis in Hungarian patients [J]. Acta Microbiol ImmunolHung,2003,50(1):33-41.
  • 5al-Jarallah KF, Buchanan WW, Sastry A, et al.Seronega- tive rheumatoid arthritis and HLA-DR4 [J]. J Rheumatol, 1994,21(2):190-193.
  • 6Haas JP, Nevinny-Stickel C, Schoenwald U, et al. Sus- ceptible and protective major histocompatibility complex class II alleles in early-onset pauciarticular juvenile chronic arthritis[J]. Hum Immunol,1994,41(3):225-233.
  • 7Seidl C, Koch U, Briinnler G, et al. HLA-DR/DQ/DP in- teractions in rheumatoid arthritis [J]. Eur J Immunogenet, 1997,24(5):365-376.
  • 8Carthy D, MacGregor A, Awomoi A, et al. HLA- DPBI*0201 is associated with particular clinical features of rheumatoid arthritis[J]. Rev Rhum Engl Ed,1995,62(3): 163-168.
  • 9Suzuki A, Yamada R, Chang X, et al. Functional haplo- types of PADI4, encoding citrullinating enzyme peptidy- larginine deiminase 4, are associated with rheumatoid arthritis[J]. Nat Genet,2003,34(4):395-402.
  • 10Suzuki A, Yamada R, Kochi Y, et al. Functional SNPs in CD244 increase the risk of rheumatoid arthritis in a Japanese population [J]. Nat Genet,2008,40 (10):1224- 1229.

引证文献4

二级引证文献16

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部